论文部分内容阅读
经CT扫描等确诊的中、重型脑损伤患者，90例加服脑复合剂（简称治疗组），60例未服用该合利（简称对照组），两组条件（病情轻重、病种、治疗方式）基本一致。结果显示，治疗组在血肿的吸收消退、临床主症的改善、GCS计分的回升方面明显优于对照组（P＜0．05或0．01），治疗组疗效显著优于对照组（p＝0．009），早期加用脑复合剂，通过活血化瘀能促进昏迷病人的苏醒及功能恢复，减少后遗症的发生率，表明中西医结合治疗该症有较好疗效。
Ninety patients with moderate and severe brain injury diagnosed by CT scan were treated with cerebrospinal fluid (90 patients) and 60 patients who did not take the combination (the control group). The two groups of conditions (severity, disease, treatment Way) basically the same. The results showed that the treatment group in the hematoma subsided, the main clinical improvement, GCS score was significantly better than the control group (P <0.05 or 0.01), the treatment group was significantly better than the control group (p = 0.009), early with brain compound, through promoting blood circulation can promote the recovery of patients with coma and functional recovery and reduce the incidence of sequelae, indicating that the combination of traditional Chinese and Western medicine treatment of the disease has a good effect.